A New Treatment Option for Heavy Menstrual Bleeding

NCT01715025 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Menorrhagia

Interventions

DRUG: E2Nomac

Sponsor

Sydney Centre for Reproductive Health Research

Collaborators

[object Object]